Latest Share Chat

REMOVE ADS

Novartis N Ord Share News (0QLR)

Novartis N Ord Information

Share Price Information for Novartis N Ord (0QLR)

Share Price is delayed by 15 minutes

Get Live Data

121.39 0.78 (0.65%)

Bid:

118.36

Ask:

124.42

Spread: 6.06 (5.12%)

Market Cap:

Last checked at -

Intraday Novartis N Ord Share Chart

This share is an international stock.

REMOVE ADS

Novartis N Ord News

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton ...

Rio Tinto Appoints Novartis Legal Head As General Counsel Executive

(Alliance News) - Rio Tinto PLC said Monday it has appointed Barbara Levi as group general counsel with effect from January 1, 2020.She will be replac...

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating t...

Oxford BioMedica Notes Kymriah Cancer Treatment's Approval In Japan

LONDON (Alliance News) - Gene and cell therapy firm Oxford BioMedica PLC on Tuesday noted a drug which uses one of its products has been approved in J...

Beximco Pharmaceuticals Acquires 14 New Drug Applications From Sandoz

LONDON (Alliance News) - Bangladeshi pharmaceutical firm Beximco Pharmaceuticals Ltd said on Wednesday it has agreed to acquire a portfolio of eight A...

Clinigen Stock Climbs As It Buys Proleukin's US Rights From Novartis

LONDON (Alliance News) - Pharmaceuticals firm Clinigen Group PLC's shares rose early Wednesday as it announced the purchase of the rights to one of No...

Oxford Biomedica Notes Results Of Longer Term Kymriah Analysis

LONDON (Alliance News) - Oxford Biomedica PLC on Monday noted the longer term analysis results for cancer drug Kymriah which showed a durable response...

TOP NEWS: Glaxo Confirms Merger Talks For Indian Nutrition Business

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday confirmed that it is considering a merger transaction for its Horlicks nutritional drinks bra...